CERE (cerevel.com) Net Income

Official company branding of Cerevel Therapeutics Inc (CERE)

Cerevel Therapeutics (CERE) relies on outsourcing for production and testing, maintaining its status as a flexible research hub. The company's operating profit on this chart confirms this model, where the indicator value is -0.46. The acquisition by the behemoth AbbVie at a premium, along with the success of drugs for schizophrenia and Parkinson's, served as the primary drivers that successfully eliminated the binary risks of a narrow clinical portfolio.

Company Net Income: Cerevel Corp (CERE) for 07/04/2022 - 08/10/2024

Comprehensive metric breakdowns and analytics for Cerevel Therapeutics, Inc. (CERE)

- stock value and consensus price forecast:
Market Price Cerevel Corp|CERE - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Cerevel Corp|CERE - Enterprise Value
- company book value details:
Net Asset Value per Share Cerevel Therapeutics|CERE - Company Book Value|Market Value to Book Value cerevel.com|CERE - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Cerevel Therapeutics|CERE - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Cerevel Therapeutics Inc|CERE - Company Aggregate Debts|Debts to Book Value Cerevel Corp|CERE - Company Long-Term Debt|Company Short-Term Debt Cerevel Therapeutics|Intermediate Coverage Ratio cerevel.com
- company profitability and valuation multiples indicators:
CERE - Net Income
Fundamental valuation:CERE Cerevel Corp
Signature product of Cerevel Therapeutics Inc

Net income reflects the business's ultimate ability to generate capital after deducting all operating expenses, allowing market noise to be separated from the fundamental trend. Analyzing the total financial result of Cerevel Therapeutics (CERE) helps assess the company's resilience amid strict FDA oversight and high development costs for proprietary drugs treating CNS disorders.

Main competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Company Net Income catalystpharma.com|DNLI (Denali Therapeutics Inc.) - Net Income|HRMY (Harmony Biosciences Inc) - Company Net Income|BHVN (Biohaven Pharmaceutical) - Net Profit|Company Net Income Amylyx Corp AMLX|Company Net Income Trevi Therapeutics (TRVI)|Company Net Income PRAX (praxismedicines.com)|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|PRTA: Net Income|Alector, Inc. - Profit After Payment of Taxes|ANNX: Net Profit|Omeros - Final Profit|NGNE (Neurogene) - Net Profit|Company Net Income AC Immune S.A. ACIU|Company Net Income Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Final Profit|Net Profit SCLX (Scilex Holding Company)|Net Profit tevogen.com TVGN|ACOG - Company Net Income|Profit After Tax CGTX|IKT: Net Profit|Company Net Income Cassava Pharma (SAVA)|Net Income ASRT|Net Profit Coya|Net Income VTGN (Vistagen Therapeutics)|Profit After Payment of Taxes OVID|Net Profit ABOS (Acumen Pharma)|Net Financial Result CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Net Profit|Clene Inc. (CLNN) - Net Income|pepgen.com (PEPG) - Company Net Income|JUNS - Net Financial Result|RLMD (Relmada) - Net Profit|Net Income Annovis Bio Corporation (ANVS)|Net Profit GRCE|AIFF - Company Net Income|Company Net Income Klotho Neurosciences KLTO|Final Profit NRSN|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NeurAxis, Inc. (NRXS) - Company Net Income|Company Profit HSDT|PASG (Passage Bio Inc.) - Net Profit|Company Net Income Neuphoria NEUP|Net Income NERV (Minerva Neurosciences Corp)|Net Profit Athira Pharma Corp (ATHA)|Company Net Income Addex Therapeutics ADXN|Final Profit ALZN|CYCN - Company Net Income|Company Net Income Protagenic Therapeutics|KTTA: Net Profit|Net Income Cortigent|ATXI (Avenue Therapeutics) - Net Profit|Company Net Income brainstorm-cell.com BCLI|Company Net Income Cara Therapeutics (CARA)|CHRO (Chromocell Therapeutics Corp) - Final Profit|Net Profit ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Company Net Income|LBPH: Net Income|MRNS: Company Net Income|NKGN: Net Profit|Company Net Income NeuroBo Pharmaceuticals Inc (NRBO)|Company Net Income Sage Therapeutics, Inc|Company Net Income SNPX|Net Income TRVN (Trevena, Inc.)|VIGL (vigilneuro.com) - Final Profit|Anew Medical, Inc. - Net Income